CELZ 4.57 Creative Medical Technology Holdings, Inc.
| Range: | 2.65-10.2812 | Vol Avg: | 15443 | Last Div: | 0 | Changes: | 0.27 |
| Beta: | 5.02 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Fri Nov 06 2015 | Empoloyees: | 4 | ||
| CUSIP: | 22529Y200 | CIK: | 0001187953 | ISIN: | US22529Y4089 | Country: | US |
| CEO: | Mr. Timothy Warbington | Website: | https://www.creativemedicaltechnology.com | ||||
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow